Alveron Pharma

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Cayuga Biotech

This company develops biomimetic injectable drugs to control life-threatening hemorrhage for patients suffering from trauma, childbirth complications or surgical bleeding.

Aeromics

This pharmaceutical company develops an intravenous drug to treat brain swelling in patients suffering from severe ischemic stroke.

Basking Biosciences

The company develops reversible therapies targeting von Willebrand Factor for patients with acute thrombotic conditions, such as strokes.

TargED Biopharmaceuticals

The company develops targeted biological drugs to treat thrombotic diseases such as acute ischaemic stroke and immune-mediated thrombotic thrombocytopenic purpura for healthcare providers.